Alembic Pharmaceuticals Ltd (BOM:533573)
₹ 1039 -42.45 (-3.93%) Market Cap: 204.23 Bil Enterprise Value: 213.40 Bil PE Ratio: 31.60 PB Ratio: 4.18 GF Score: 91/100

Q2 2021 Alembic Pharmaceuticals Ltd Earnings Call Transcript

Oct 22, 2020 / 11:30AM GMT
Release Date Price: ₹1011.6 (+1.46%)
Operator

Ladies and gentlemen, good day, and welcome to the Q2 H1 FY '21 Earnings Conference Call of Alembic Pharmaceuticals Limited.

We have with us today on the call Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance, and CFO; Mr. Mitanshu Shah, Head of Finance; Mr. Jesal Shah, Head of Strategy; and Mr. Ajay Kumar Desai, Senior VP, Finance. (Operator Instructions) Please note that this conference is being recorded.

I would now like to hand the conference over to Mr. R.K. Baheti, Director of Finance and CFO. Thank you, and over to you, sir.

Raj Kumar Shreeram Baheti
Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director

Thank you, ma'am. Good evening, everyone. Sincere thanks for joining our second quarter results conference call. As a change this time, we had a Board meeting in the afternoon. But I'm sure you would have got the results by now. I'll briefly take you through the numbers for quarter ended 30th of September 2020.

Financials. During the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot